Skip to main content
. 2008 Fall;10(4):262–280.

Table 3.

Prostate Biopsy Nomograms for Prediction of Prostate Cancer Presence in Initial Biopsy Setting

Reference Prediction Form Number of Patients Variables Mean Number of Cores (Range) Cancer Detection Rate (%) Accuracy (%) Validation
Babaian RJ et al.131 Risk group 151 Age, creatinine phosphokinase isoenzyme activity, prostatic acid phosphatase, PSA 6 24 74 Not performed
Eastham JA et al110 Probability nomogram development 700 Age, race, DRE, PSA (0–4 ng/mL) 6 9 75 Internal
Virtanen A et al132 Neural network 212 Percentage free PSA, DRE, heredity Not available 25 81 Not performed
Finne P et al133 Neural network 656 Percentage free PSA, PSA, DRE, TRUS Not available 23 Not available Not performed
Horninger W et al134 Neural network 3474 Age, PSA, percentage free PSA, DRE, TRUS, PSA density, PSA density of transition zone, transition zone volume Not available Not available Not available Not performed
Kalra P et al135 Neural network 348 Age, ethnicity, heredity, IPSS, DRE, PSA, complexed PSA 6 Not available 83 Not performed
Garzotto M et al111 Probability nomogram development 1239 Age, race, family history, referral indications, prior vasectomy, DRE, PSA (≤ 10 ng/mL), PSA density, TRUS findings 6.7 (6–13) 24 73 Not performed
Finne P et al136 Neural network 1775 DRE, percentage free PSA, TRUS, PSA Not available 22 76 Not performed
Karakiewicz PI et al112 Probability nomogram development 6469 Age, DRE, PSA, percentage free PSA 6 35–42 77 Internal and external
Suzuki H et al137 Probability nomogram development 834 Age, PSA, percentage free PSA, prostate volume, DRE ≥ 6 29 82 Internal
Chun FK et al128 Probability nomogram validation112 and development 2900 Age, DRE, PSA, percentage free PSA, sampling density* 11 (10–20) 41 77 Internal and external
Porter CR et al138 Neural network 3814 Age, PSA, gland volume, PSA density, DRE, TRUS 6 27–42 72–75 Internal and external
*

Sampling density = ratio of TRUS-derived total gland volume by the number of cores at biopsy.

DRE, digital rectal examination; IPSS, International Prostate Symptom Score; PSA, prostate-specific antigen; TRUS, transrectal ultrasound of the prostate.